MENU
+Compare
COYA
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$5.38
Change
-$0.22 (-3.93%)
Capitalization
89.89M

COYA Coya Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for COYA with price predictions
Jan 08, 2025

COYA in -1.72% downward trend, sliding for three consecutive days on January 02, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where COYA declined for three days, in of 127 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for COYA entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where COYA's RSI Indicator exited the oversold zone, of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 31, 2024. You may want to consider a long position or call options on COYA as a result. In of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COYA just turned positive on December 27, 2024. Looking at past instances where COYA's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COYA advanced for three days, in of 99 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.808) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). COYA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (7.831) is also within normal values, averaging (264.084).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. COYA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

COYA is expected to report earnings to rise 53.85% to -40 cents per share on March 26

Coya Therapeutics COYA Stock Earnings Reports
Q4'24
Est.
$-0.40
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.42
Q1'24
Missed
by $0.06
Q4'23
Missed
by $0.12
The last earnings report on November 06 showed earnings per share of -25 cents, beating the estimate of -36 cents. With 63.99K shares outstanding, the current market capitalization sits at 89.89M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5850 San Felipe Street
Phone
+1 800 587-8170
Employees
8
Web
https://www.coyatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURV6.270.27
+4.50%
Torrid Holdings
ERO14.150.25
+1.80%
Ero Copper Corp
EBKDY31.260.26
+0.82%
Erste Group Bank AG
SWIN1.760.01
+0.57%
Solowin Holdings Ordinary Share
SUHJY8.92-0.02
-0.22%
Sun Hung Kai Properties Ltd.

COYA and Stocks

Correlation & Price change

A.I.dvisor tells us that COYA and IVVD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COYA and IVVD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-3.93%
IVVD - COYA
30%
Poorly correlated
-7.49%
KNSA - COYA
29%
Poorly correlated
+0.82%
NTLA - COYA
29%
Poorly correlated
+0.85%
IOVA - COYA
28%
Poorly correlated
+2.60%
ENTA - COYA
28%
Poorly correlated
+8.25%
More